長崎大学経済学部

研究活動

Abstract:
This paper analyzes the strategic alliances in the emerging bio-pharma industry in Asia as bio-pharma companies pursue multiple sources of competitive advantage in an industry that has become more global and where competition has become more fierce and pressure for cost, time and innovation is high. How these firms form alliances that bring together complementary competences and assets, facilitate entry into a foreign market and increase market presence , and spread and reduce costs of innovation in order to survive in the domestic and international market will likewise be presented.